Should minimal residual disease monitoring be the standard of care for all patients with acute promyelocytic leukemia? Editorial Article uri icon

Overview

MeSH Major

  • Leukemia, Promyelocytic, Acute
  • Monitoring, Physiologic
  • Neoplasm, Residual

publication date

  • January 2011

Research

keywords

  • Editorial

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.leukres.2010.06.018

PubMed ID

  • 20674017

Additional Document Info

start page

  • 3

end page

  • 7

volume

  • 35

number

  • 1